Li, M., Zhang, S., Ma, Y., Yang, Y., & An, R. (2021). Role of hsa-miR-105 during the pathogenesis of paclitaxel resistance and its clinical implication in ovarian cancer. Oncol Rep.
Chicago Style CitationLi, Mao, Shun Zhang, Yuan Ma, Yang Yang, and Ruifang An. "Role of Hsa-miR-105 During the Pathogenesis of Paclitaxel Resistance and Its Clinical Implication in Ovarian Cancer." Oncol Rep 2021.
MLA CitationLi, Mao, et al. "Role of Hsa-miR-105 During the Pathogenesis of Paclitaxel Resistance and Its Clinical Implication in Ovarian Cancer." Oncol Rep 2021.
Warning: These citations may not always be 100% accurate.